» Articles » PMID: 34163032

NF-κB-activated SPRY4-IT1 Promotes Cancer Cell Metastasis by Downregulating TCEB1 MRNA Via Staufen1-mediated MRNA Decay

Overview
Journal Oncogene
Date 2021 Jun 24
PMID 34163032
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Previous study demonstrated that most long non-coding RNAs (lncRNAs) function as competing endogenous RNAs or molecular sponges to negatively modulate miRNA and regulate tumor development. However, the molecular mechanisms of lncRNAs in cancer are not fully understood. Our study describes the role of the lncRNA SPRY4 intronic transcript 1 (SPRY4-IT1) in cancer metastasis by mechanisms related to Staufen1 (STAU1)-mediated mRNA decay (SMD). Briefly, we found that, high SPRY4-IT1 expression was associated with aggressiveness and poor outcome in human colorectal, breast and ovarian cancer tissues. In addition, functional assays revealed that SPRY4-IT1 significantly promoted colorectal, breast and ovarian cancer metastasis in vitro and in vivo. Mechanistically, microarray analyses identified several differentially-expressed genes upon SPRY4-IT1 overexpression in HCT 116 colorectal cancer cells. Among them, the 3'-UTR of transcription elongation factor B subunit 1 (TCEB1) mRNA can base-pair with the Alu element in the 3'-UTR of SPRY4-IT1. Moreover, SPRY4-IT1 was found to bind STAU1, promote STAU1 recruitment to the 3'-UTR of TCEB1 mRNA, and affect TCEB1 mRNA stability and expression, resulting in hypoxia-inducible factor 1α (HIF-1α) upregulation, and thereby affecting cancer cell metastasis. In addition, STAU1 depletion abrogated TCEB1 SMD and alleviated the pro-metastatic effect of SPRY4-IT1 overexpression. Significantly, we revealed that SPRY4-IT1 is also transactivated by NF-κB/p65, which activates SPRY4-IT1 to inhibit TCEB1 expression, and subsequently upregulate HIF-1α. In conclusion, our results highlight a novel mechanism of cytoplasmic lncRNA SPRY4-IT1 in which SPRY4-IT1 affecting TCEB1 mRNA stability via STAU1-mediated degradation during cancer metastasis.

Citing Articles

lncRNAs: the unexpected link between protein synthesis and cancer adaptation.

Gugnoni M, Kashyap M, Wary K, Ciarrocchi A Mol Cancer. 2025; 24(1):38.

PMID: 39891197 PMC: 11783725. DOI: 10.1186/s12943-025-02236-7.


ANKRD1 Promotes Breast Cancer Metastasis by Activating NF-B-MAGE-A6 Pathway.

Diskul-Na-Ayudthaya P, Bae S, Bae Y, Van N, Kim W, Ryu S Cancers (Basel). 2024; 16(19).

PMID: 39409926 PMC: 11476229. DOI: 10.3390/cancers16193306.


TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis.

Deng Z, Li B, Wang W, Xia W, Zhang L, Chen L Eur J Med Res. 2024; 29(1):456.

PMID: 39261917 PMC: 11389485. DOI: 10.1186/s40001-024-02050-9.


The role of lncRNA binding to RNA‑binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review).

Zhang N, Wen K Oncol Rep. 2024; 52(5).

PMID: 39219266 PMC: 11378159. DOI: 10.3892/or.2024.8801.


STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer.

Liu X, Chen Y, Li Y, Bai J, Zeng Z, Wang M Biol Direct. 2024; 19(1):59.

PMID: 39080743 PMC: 11288052. DOI: 10.1186/s13062-024-00506-w.


References
1.
Chaffer C, Weinberg R . A perspective on cancer cell metastasis. Science. 2011; 331(6024):1559-64. DOI: 10.1126/science.1203543. View

2.
Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

3.
Ren Y, Jia H, Xu Y, Zhou X, Zhao X, Wang Y . Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion. Mol Cancer. 2018; 17(1):5. PMC: 5765658. DOI: 10.1186/s12943-018-0758-4. View

4.
Li W, Kang Y . A new Lnc in metastasis: long noncoding RNA mediates the prometastatic functions of TGF-β. Cancer Cell. 2014; 25(5):557-9. PMC: 4091806. DOI: 10.1016/j.ccr.2014.04.014. View

5.
Liang H, Yu T, Han Y, Jiang H, Wang C, You T . LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018; 17(1):119. PMC: 6087007. DOI: 10.1186/s12943-018-0870-5. View